Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Human prostate cancer is characterized by multiple gross chromosome alterations involving several chromosome regions. However, the specific genes involved in the development of prostate tumors are still largely unknown. Here we have studied the chromosome composition of the three established prostate cancer cell lines, LNCaP, PC-3, and DU145, by spectral karyotyping (SKY). SKY analysis showed complex karyotypes for all three cell lines, with 87, 58/113, and 62 chromosomes, respectively. All cell lines were shown to carry structural alterations of chromosomes 1, 2, 4, 6, 10, 15, and 16; however, no recurrent breakpoints were detected. Compared to previously published findings on these cell lines using comparative genomic hybridization, SKY revealed several balanced translocations and pinpointed rearrangement breakpoints. The SKY analysis was validated by fluorescence in situ hybridization using chromosome-specific, as well as locus-specific, probes. Identification of chromosome alterations in these cell lines by SKY may prove to be helpful in attempts to clone the genes involved in prostate cancer tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Y translocations have been documented in cell lines, for example, in prostate cell line DU 145.48”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [48]
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Two types of chromosome translocation patterns have been suggested to be involved in human malignancy (Lengauer et al., 1998).”
BackgroundEstablishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,156
ISCN 1995 An international system for human cytogenetic nomenclature
Mitelman, F. (1995) · Cited by 1,930
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar-Am, I., Soenksen, D., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,755
Karyotyping human chromosomes by combinatorial multi-fluor FISH
Speicher, M. R., Ballard, S. G., & Ward, D. C. (1996) · Nature Genetics · doi:10.1038/ng0496-368 · Cited by 1,270
Isolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Wu, H., Hsieh, J., Gleave, M. E., Brown, N. M., Pathak, S., & Chung, L. W. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570319 · Cited by 499
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi, T., Kallioniemi, A. H., Syvänen, A. C., HYYTINEN, E.-R., Karhu, R., Tammela, T. L. J., Isola, J. J., & Kallioniemi, O. (1995) · PubMed · Cited by 480
Self-citation
Research works printed but not linked: 1
- 10.1002/(sici)1097-0045(19990301)38:4<303::aid-pros6>3.3.co;2-5 · doi:10.1002/(sici)1097-0045(19990301)38:4<303::aid-pros6>3.3.co;2-5
Cited by
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C.-H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,634
Molecular characterization of human prostate carcinoma cell lines
van Bokhoven, A., Varella‐Garcia, M., Korch, C., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., & Lucia, M. S. (2003) · The Prostate · doi:10.1002/pros.10290 · Cited by 633
Upregulation of Cyclin B1 by miRNA and its implications in cancer
Huang, V., Place, R. F., Portnoy, V., Wang, J., Qi, Z., Jia, Z., Yu, A., Shuman, M., Yu, J., & Li, L.-C. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr934 · Cited by 289
Prostate cancer between prognosis and adequate/proper therapy.
Grozescu, T., & Popa, F. (2017) · PubMed Central · Cited by 177
Telomere dysfunction, genome instability and cancer
Cheung, A. (2008) · Frontiers in Bioscience · doi:10.2741/2825 · Cited by 139
Wang, Y., Xue, H., Cutz, J., Bayani, J., Mawji, N. R., Chen, W. G., Goetz, L., Hayward, S. W., Sadar, M. D., Gilks, C. B., et al. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700335 · Cited by 118
Genetic alterations in juvenile nasopharyngeal angiofibromas
Coutinho‐Camillo, C. M., Brentani, M. M., & Nagai, M. A. (2008) · Head & Neck · doi:10.1002/hed.20775 · Cited by 110
Genetic aberrations in prostate cancer by microarray analysis
Saramäki, O. R., Porkka, K. P., Vessella, R. L., & Visakorpi, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.21976 · Cited by 99
Self-citationAmplification of urokinase gene in prostate cancer.
Helenius, M. A., Saramäki, O. R., Linja, M. J., Tammela, T. L. J., & Visakorpi, T. (2001) · PubMed · Cited by 70
Self-citationMolecular cytogenetics of prostate cancer
Nupponen, N. N., & Visakorpi, T. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20001201)51:5<456::aid-jemt8>3.0.co;2-h · Cited by 69
Self-citationHermans, K. G., van Alewijk, D. C., Veltman, J. A., van Weerden, W. M., van Kessel, A. G., & Trapman, J. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10311 · Cited by 66
Applications of SKY in Cancer Cytogenetics
Bayani, J., & Squire, J. A. (2002) · Cancer Investigation · doi:10.1081/cnv-120001183 · Cited by 65
Basic Science Review: Nitric Oxide—Releasing Prosthetic Materials
Varu, V. N., Tsihlis, N. D., & Kibbe, M. R. (2009) · Vascular and Endovascular Surgery · doi:10.1177/1538574408322752 · Cited by 58
Takaha, N., Hawkins, A. L., Griffin, C. A., Isaacs, W. B., & Coffey, D. S. (2002) · PubMed · Cited by 63
Comparative Genomic and Transcriptomic Analyses of LNCaP and C4-2B Prostate Cancer Cell Lines
Spans, L., Helsen, C., Clinckemalie, L., den Broeck, T. V., Preković, S., Joniau, S., Lerut, E., & Claessens, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090002 · Cited by 59
Beheshti, B., Park, P. C., Sweet, J., Trachtenberg, J., Jewett, M. A. S., & Squire, J. A. (2001) · Neoplasia · doi:10.1038/sj.neo.7900125 · Cited by 58
Amplification of hypoxia-inducible factor 1α gene in prostate cancer
Saramäki, O. R., Savinainen, K., Nupponen, N. N., Bratt, O., & Visakorpi, T. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00396-x · Cited by 57
Self-citationSpectral karyotype (SKY) analysis of human prostate carcinoma cell lines
van Bokhoven, A., Caires, A., Maria, M. D., Schulte, A. P., Lucia, M. S., Nordeen, S. K., Miller, G. J., & Varella‐Garcia, M. (2003) · The Prostate · doi:10.1002/pros.10291 · Cited by 56
Korch, C., Hall, E. M., Dirks, W. G., Ewing, M., Faries, M., Varella‐Garcia, M., Robinson, S., Storts, D., Turner, J. A., Wang, Y., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31067 · Cited by 54
“Y translocations have been documented in cell lines, for example, in prostate cell line DU 145.(48) Y/22 translocations can also be associated with cancer, usually in association with a variant Philadelphia chromosome.”
BackgroundChromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization
Laitinen, S., Karhu, R., Sawyers, C. L., Vessella, R. L., & Visakorpi, T. (2002) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10097 · Cited by 45
Self-citation5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines
Pan, Y., Lui, W.-O., Nupponen, N., Larsson, C., Isola, J., Visakorpi, T., Bergerheim, U. S. R., & Kytölä, S. (2001) · Genes, Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999<::aid-gcc1075>3.0.co;2-h · Cited by 36
Self-citationChromosome compartmentalization alterations in prostate cancer cell lines model disease progression
Martin, R. S., Das, P., Marques, R. D. R., Xu, Y., Roberts, J. M., Sanders, J. T., Golloshi, R., & McCord, R. P. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202104108 · Cited by 45
Buchanan, G., Craft, P., Yang, M., Cheong, A., Prescott, J., Li, J., Coetzee, G. A., & Tilley, W. D. (2004) · The Prostate · doi:10.1002/pros.20079 · Cited by 44
Fadl-Elmula, I. M., Kyt�l�, S., Pan, Y., Lui, W., Derienzo, G., Forsberg, L. E., Mandahl, N., Gorunova, L., Bergerheim, U. S. R., Heim, S., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1267 · Cited by 44
Self-citationLu, X., Harris, C., Cooley, L. D., Margolin, J., Steuber, P., Sheldon, M., Rao, P. H., & Lau, C. (2002) · Leukemia · doi:10.1038/sj.leu.2402662 · Cited by 41
Aurich‐Costa, J., Vannier, A., Grégoire, E., Nowak, F., & Chérif, D. (2001) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999<::aid-gcc1076>3.0.co;2-e · Cited by 39
Differential expression of hZnT‐4 in Human prostate tissues
Beck, F. W. J., Prasad, A. S., Butler, C. E., Sakr, W., Küçük, Ö., & Sarkar, F. H. (2003) · The Prostate · doi:10.1002/pros.10344 · Cited by 39
Deletion of chromosomal region 6q14‐16 in prostate cancer
Verhagen, P. C. M. S., Hermans, K. G., Brok, M. O., van Weerden, W. M., Tilanus, M. G. J., de Weger, R. A., Boon, T. A., & Trapman, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10677 · Cited by 34
Effect of p53 on centrosome amplification in prostate cancer cells
Ouyang, X., Wang, X., Xu, K., Jin, D., Cheung, A. L. M., Tsao, S. W., & Wong, Y. C. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00157-4 · Cited by 34
Strefford, J. C., Lillington, D. M., Young, B. D., & Oliver, R. T. D. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00339-3 · Cited by 33
Wang, L.-Y., & Kung, H.-J. (2011) · Oncogene · doi:10.1038/onc.2011.464 · Cited by 31
Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
Devlies, W., Handle, F., Devos, G., Joniau, S., & Claessens, F. (2021) · Cancers · doi:10.3390/cancers13040915 · Cited by 28
Schröck, E., Zschieschang, P., O´Brien, P. C. M., Helmrich, A., Hardt, T., Matthaei, A., & Stout‐Weider, K. (2006) · Cytogenetic and Genome Research · doi:10.1159/000094203 · Cited by 28
Multicolor spectral karyotyping of serous ovarian adenocarcinoma
Rao, P. H., Harris, C. P., Lü, X., Li, X. N., Mok, S. C., & Lau, C. C. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1221 · Cited by 28
Danziger, O., Shai, B., Sabo, Y., Bacharach, E., & Ehrlich, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10313 · Cited by 25
Variations in the exome of the LNCaP prostate cancer cell line
Spans, L., Atak, Z. K., Nieuwerburgh, F. V., Deforce, D. L. D., Lerut, E., Aerts, S., & Claessens, F. (2011) · The Prostate · doi:10.1002/pros.22480 · Cited by 22
Varella‐Garcia, M., Boomer, T., & Miller, G. J. (2001) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.1149 · Cited by 21
Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence
Murillo, H., Schmidt, L. J., Karter, M., Hafner, K. A., Kondo, Y., Ballman, K. V., Vasmatzis, G., Jenkins, R. B., & Tindall, D. J. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20333 · Cited by 21
Pang, S., Weng, W., Flores‐Morales, A., Johansson, B. A., Pourian, M. R., Nilsson, P., Pousette, Å., Larsson, C., & Norstedt, G. (2005) · The Prostate · doi:10.1002/pros.20328 · Cited by 21
Self-citationThe yin and yang of chromosomal instability in prostate cancer
Carceles‐Cordon, M., Orme, J. J., Domenech, J. M. D., & Rodríguez-Bravo, V. (2024) · Nature Reviews Urology · doi:10.1038/s41585-023-00845-9 · Cited by 15
Giráldez‐Pérez, R. M., Grueso, E., Montero‐Hidalgo, A. J., Luque, R. M., Carnerero, J. M., Kuliszewska, E., & Prado‐Gotor, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415575 · Cited by 15
Khalil, A. I. S., Khyriem, C., Chattopadhyay, A., & Sanyal, A. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3480-3 · Cited by 14
Sweeney, J. D., Debeljak, M., Riel, S. L., Millena, A. C., Eshleman, J. R., Paller, C. J., & Odero-Marah, V. (2021) · Antioxidants · doi:10.3390/antiox10020213 · Cited by 14
Cofré, J., Saalfeld, K., & Abdelhay, E. (2019) · The Scientific World JOURNAL · doi:10.1155/2019/4714781 · Cited by 13
Sankoff, D., & Nadeau, J. H. (2000) · Computational biology · doi:10.1007/978-94-011-4309-7_1 · Cited by 13
Anker, J. F., Mok, H., Naseem, A. F., Thumbikat, P., & Abdulkadir, S. A. (2018) · Journal of Visualized Experiments · doi:10.3791/57301-v · Cited by 12
Molecular characterization of a consistent 4.5-megabase deletion at 4q28 in prostate cancer cells
Matsui, S., LaDuca, J. R., Rossi, M. R., Nowak, N. J., & Cowell, J. K. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.09.010 · Cited by 12
Strefford, J. C., Lane, T., Hill, A. S., LeRoux, L., Foot, N. J., SHIPLEY, J. M., Oliver, R. T. D., Lu, Y., & Young, B. D. (2005) · Cytogenetic and Genome Research · doi:10.1159/000087512 · Cited by 11
Fate of the human Y chromosome linked genes and loci in prostate cancer cell lines DU145 and LNCaP
Yadav, S. K., Kumari, A., & Ali, S. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-323 · Cited by 10
Chiorino, G., Acquadro, F., Grand, M. M., Viscomi, S., Segir, R., Gasparini, M., & Dotto, P. H. F. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.029 · Cited by 10
Riches (2010) · Oncology Reports · doi:10.3892/or_00001050 · Cited by 4
Gene Copy Number Alterations in Prostate Cancer
Saramäki, O. R. (2006) · Tampere University Institutional Repository (Tampere University) · Cited by 2
Bokhoven, A. V. (2004) · Radboud Repository (Radboud University) · Cited by 2
Functional characterization of sequential in vitro model of prostate tumorigenesis
Kultanen, H. (2024) · Tampere University Institutional Repository (Tampere University) · Cited by 2
Gäberlein, K., Keller, D. T., Schröder, S. K., Torkler, P., Grimm, D. G., Steinlein, C., Haaf, T., Nanda, I., & Weiskirchen, R. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1730948 · Cited by 1
Characterization of Chromosomal Abnormalities in Cancer by Spectral Karyotyping
Abubakar, S. D. (2019) · Medical Laboratory Journal · doi:10.29252/mlj.13.6.1 · Cited by 1
Romão, P., Souza, Í. D. C., da Silva, I., Guimarães, V., de Camargo, J. A., dos Santos, G. A., Viana, N. I., Srougi, M., Leite, K. R. M., Reis, S. T., et al. (2022) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2021.10.003 · Cited by 1
Solving Problems in Multiplex FISH
Strefford, J. C. (2003) · Humana Press eBooks · doi:10.1385/1-59259-363-1:235 · Cited by 1
Genetic Analysis of Prostate Cancer
van Alewijk, D. (2003) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Wurster, S. (2012) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-2787 · Cited by 1
O papel dos microRNAs -221/-222 e -23b/-27b no câncer de próstata resistente à castração
Pimenta, R. C. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-28032018-130112 · Cited by 1
Genetic Analysis of Clinical Prostate Cancer
Verhagen, P. C. M. S. (2005) · RePub (Erasmus University Rotterdam)
Unraveling of the major genetic defects in prostate cancer
Hermans, K. G. (2009) · EUR Research Repository (Erasmus University Rotterdam)
Stempfhuber, M. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3718
Digital karyotyping of cancer cell lines from NGS data
Khalil, A. I. S. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/138176
Romão, P., Souza, Í. D. C., da Silva, I., Guimarães, V., de Camargo, J. A., dos Santos, G. A., Viana, N. I., Srougi, M., Leite, K. R. M., Reis, S. T., et al. (2021) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2020.11.012
Friedrich, C. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-858
Comparison of Two Budding Yeast Disome Model Systems: Similarities, Difference, and ConflictPreprint
Vinton, P. J., & Langston, R. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.11.519961
Genomic analyses of high-risk prostate cancer
Spans, L. (2014) · Lirias
Spontaneous Cell Fusion as the Mechanism of Cancer Progression and Metastasis
Ruoxiang, W. (2026) · iMed · doi:10.70322/imed.2026.10004
Metadata
- Authors
- Pan, Y., Kytölä, S., Farnebo, F., Wang, N., Lui, W. O., Nupponen, N., Isola, J., Visakorpi, T., Bergerheim, U. S. R., & Larsson, C.
- Affiliations
- Karolinska University Hospital (SE)
- Tampere University Hospital (FI)
- Venue
- Cytogenetic and Genome Research
- Publisher
- S. Karger AG
- Published
- 1999
- Volume
- 87
- Issue
- 3-4
- Pages
- 225-232
- ISSN
- 1424-859X (ISSN-L)
- 1424-8581
- OpenAlex
- W1975308167
- Cited by
- 63
- References
- 39
- Citations by year
- 2026: 2 · 2024: 1 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cytogenetic and Genome Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genome Rearrangement Algorithms
- Keywords
- prostate cancer, chromosomal abnormalities, spectral karyotyping, prostate cancer cell lines, LNCaP cells, PC-3 cells, DU145 cells, balanced translocation, chromosomal rearrangements
- MeSH terms
- Aneuploidy, Chromosome Aberrations, Chromosomes, Human, Pair 8, Humans, Karyotyping, Male, Nucleic Acid Hybridization, Prostatic Neoplasms, Translocation, Genetic, Tumor Cells, Cultured, Reproducibility of Results, In Situ Hybridization, Fluorescence, Chromosome Breakage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.